Pay attention to the detection and evaluation of CD30 in pathological diagnosis of lymphoma.
10.3760/cma.j.cn112151-20211119-00848
- Author:
Zhi Hong ZHANG
1
Author Information
1. Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Ki-1 Antigen;
Lymphoma/pathology*
- From:
Chinese Journal of Pathology
2022;51(4):287-289
- CountryChina
- Language:Chinese
-
Abstract:
CD30 is a transmembrane glycoprotein of tumor necrosis factor receptor family, which is expressed differently in various lymphomas. It has specific effects on the proliferation and function of tumor cells. However, the significance of CD30 expression has not been fully recognized by clinicians and pathologists, and the detection and evaluation of CD30 have not been standardized. The role of CD30 in the diagnosis of lymphoma, detection methods and reporting standards are summarized in the paper to improve the understanding of CD30.
